Bullish and Bearish Reversals for the Week

Technology stocks dominate the bearish ledger this week.
Stocks quotes in this article: KR, PGR, HCA, LUV, CHTR, NWSA, P, PAG, UL, ABBV, AGEN, ILMN, MDT, DOV, TRN, ACIA, AMAT, AMBA, BOX, CIEN, DDD, FTNT, OCLR, STX, VEEV

Below is a list of names for those charts we believe are showing technical characteristics of either bullish or bearish reversal patterns that occurred over the past week.

Bullish reversals imply institutional accumulation and the potential for higher prices.

Bearish reversals imply institutional distribution and the potential for lower prices. Each group is listed by sector affiliation.

Bullish Reversals:

Consumer Defensives: Kroger (KR)

Financial Services: Progressive (PGR)

Health Care: HCA Holdings (HCA)

Industrials: Southwest Airlines (LUV)

Bearish Reversals:

Communication Services: Charter Communications (CHTR)

Consumer Cyclicals: News Corp. (NWSA) , Pandora Media (P) , Penske Automotive Group (PAG)

Consumer Defensive: Unilever (UL)

Health Care: AbbVie (ABBV) , Agenus (AGEN) , Illumina (ILMN) , Medtronic (MDT)

Industrials: Dover (DOV) , Trinity Industries (TRN)

Technology: Acacia Communications (ACIA) , Applied Materials (AMAT) , Ambarella (AMBA) , Box (BOX) , Ciena (CIEN) , 3D Systems (DDD) , Fortinet (FTNT) , Oclaro (OCLR) , Seagate Technology (STX) , Veeva Systems (VEEV)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Ortmann had no positions in the securities mentioned.

TAGS: Investing | U.S. Equity | Stocks

More from Investing

Price Targets: How They Mislead and How They Can be Used

James "Rev Shark" DePorre

The main problem with price targets is that they are a static number in a dynamic situation.

Stock Market Continues to Defy Conventional Wisdom

James "Rev Shark" DePorre

Concerns about the action being overheated remain, but rotational action keeps the momentum going.

AMC Is a High Risk, High Reward Play

Timothy Collins

Short and sweet: This is based on the high running emotions of the markets. There's little to it beyond that.

GoodRx Needs a Shot in the Arm to Improve Its Outlook

Bruce Kamich

IPOs in recent months have done extremely well -- not so GDRX.

2021 and 2022 Look Difficult for Intel, While 2023 -- Might -- Be Better

Eric Jhonsa

Competition from AMD and ARM CPU developers looks set to take a toll over the next two years. But Intel could be in better shape in 2023 if its new CEO is ready to make some tough choices.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight